✦ LIBER ✦

Entering the Era of Targeted Therapy for Chronic Lymphocytic Leukemia: Impact on the Practicing Clinician

✍ Scribed by Byrd, J. C.; Jones, J. J.; Woyach, J. A.; Johnson, A. J.; Flynn, J. M.

Book ID: 127328164
Publisher: American Society of Clinical Oncology
Year: 2014
Tongue: English
Weight: 187 KB
Volume: 32
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2014.55.8262

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lymphocytes, B lymphocytes, and clonal C

Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for Chronic Lymphocytic Leukemia (CLL)

✍ Mulligan, C. S.; Thomas, M. E.; Mulligan, S. P. 📂 Article 📅 2009 🏛 American Society of Hematology 🌐 English ⚖ 167 KB

The impact of initial fludarabine therap

The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011)

✍ Solh, Melhem; Rai, Kanti R.; Peterson, Bercedis L.; Kolitz, Jonathan E.; Appelba 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 571 KB

Time for a new era in the evaluation of

Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: Inclusion of quality of life and other patient-reported outcomes

✍ F. Efficace; K. Cocks; M. Breccia; M. Sprangers; C.A. Meyers; M. Vignetti; M. Ba 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Analysis of the impact of imatinib mesyl

Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome–positive chronic myelogenous leukemia treated with interferon-α regimens for early chronic phase

✍ Hagop Kantarjian; Susan O'Brien; Jorges Cortes; Jianqin Shan; Francis Giles; Gui 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

## Abstract ## BACKGROUND The effect on prognosis of adding imatinib mesylate to the treatment of patients with Philadelphia chromosome (Ph)‐positive chronic myelogenous leukemia (CML) has not been explored fully. The objective of the current study was to evaluate the benefit of adding imatinib to

Impact of imatinib therapy on the use of

Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia

✍ Sergio A. Giralt; Mukta Arora; John M. Goldman; Stephanie J. Lee; Richard T. Maz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

Eradication of Minimal Residual Disease

Eradication of Minimal Residual Disease with Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients: The Need for a Standard Method of Detection and the Potential Impact of Bone Marrow Clearance on Disease Outcome

✍ Montillo, Marco; Schinkoethe, Timo; Elter, Thomas 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 133 KB